The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression

Autor: Bryant, RJ, Oxley, J, Young, GJ, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Goepel, JR, Varma, M, Griffiths, DF, Grigor, K, Mayer, N, Warren, AY, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, DJ, F Catto, JW, Neal, DE, Donovan, JL, Hamdy, FC, Protect Study Group, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E

Publikováno v: Bryant, R J, Oxley, J, Young, G J, Lane, J A, Metcalfe, C, Davis, M, Turner, E L, Martin, R M, Goepel, J R, Varma, M, Griffiths, D F, Grigor, K, Mayer, N, Warren, A Y, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, D J, F Catto, J W, Neal, D E, Donovan, J L, Hamdy, F C, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E & the ProtecT Study Group 2020, ' The ProtecT trial : analysis of the patient cohort, baseline risk stratification and disease progression ', BJU International . https://doi.org/10.1111/bju.14987

OBJECTIVES: The ProtecT (Prostate testing for cancer and Treatment) trial randomised 1,643 men with localised prostate cancer (PCa) to active monitoring, radical prostatectomy or radical radiotherapy. At 10-year median follow-up there were no differe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f116adeea8a4a0e19e6d297cd979bd54
https://doi.org/10.1111/bju.14987

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

Autor: Latif, Z, Watters, A.D, Dunn, I, Grigor, K, Underwood, M.A, Bartlett, J.M.S

Publikováno v: In European Journal of Cancer January 2004 40(1):56-63

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

Autor: Catto, J. W. F., Robinson, M. C., Albertsen, P. C., Goepel, J. R., Abbod, M. F., Linkens, D. A., Davis, M., Rosario, D. J., Warren, A. Y., Varma, M., Griffiths, D. F., Grigor, K. M., Mayer, N. J., Oxley, J. D., Deshmukh, N. S., Lane, J. A., Metcalfe, C., Donovan, J. L., Neal, D. E., Hamdy, F. C., ProtecT Study Grp, P. S. G.

Publikováno v: British Journal of Cancer

This article is available through a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. Copyright @ 2011 Cancer Research UK. Background: Contemporary screening for prostate cancer frequently identifies small volume, low-grade

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eed83691a37372ffd604b03e63d2813
http://europepmc.org/articles/PMC3185935

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.